NATCAPSUQ — Natural Capsules Share Price
- IN₹2.10bn
- IN₹3.20bn
- IN₹1.55bn
- 40
- 28
- 77
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.2 | ||
Price to Tang. Book | 1.2 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.36 | ||
EV to EBITDA | 19.35 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.49% | ||
Return on Equity | 0.68% | ||
Operating Margin | 4.93% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 615.55 | 795.13 | 1,350.7 | 1,723.74 | 1,554.2 | n/a | n/a | 21.06% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -61.74 | +514.43 | +222.04 | -11.08 | -70.02 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in manufacturing an array of capsules, including hard gelatin capsules, vegetarian capsules, and various specialty variants. The Company offers a diverse range of capsule products to both domestic and international markets, serving the pharmaceutical and nutraceutical industries. Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. It has two manufacturing facilities that are located in Bengaluru and Puducherry.
Directors
- C. Rangachar NEC
- Prasanna Junnarkar CFO
- Shilpa Burman CCO
- Sunil Mundra MDR
- Laxminarayan Moondra EDR
- Satyanarayan Mundra EDR
- Jyothi Mundra DRC
- Sushil Mundra NED
- C. Gurumurthy NID
- Anjan Roy NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 20th, 1993
- Public Since
- August 3rd, 1994
- No. of Shareholders
- 11,290
- No. of Employees
- 169
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 10,341,154

- Address
- 102, "Shreshta Bhumi" No. 87 K.R. Road, BANGALORE, 560011
- Web
- https://www.naturalcapsules.com/
- Phone
- +91 8026561562
- Auditors
- M/s. P.Chandrasekar
Upcoming Events for NATCAPSUQ
Natural Capsules Ltd Annual Shareholders Meeting
Q1 2026 Natural Capsules Ltd Earnings Release
Similar to NATCAPSUQ
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 22:12 UTC, shares in Natural Capsules are trading at IN₹216.37. This share price information is delayed by 15 minutes.
Shares in Natural Capsules last closed at IN₹216.37 and the price had moved by over the past 365 days. In terms of relative price strength the Natural Capsules share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreNatural Capsules does not currently pay a dividend.
Natural Capsules does not currently pay a dividend.
Natural Capsules does not currently pay a dividend.
To buy shares in Natural Capsules you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹216.37, shares in Natural Capsules had a market capitalisation of IN₹2.10bn.
Here are the trading details for Natural Capsules:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: NATCAPSUQ
Based on an overall assessment of its quality, value and momentum Natural Capsules is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Natural Capsules. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹216.37, shares in Natural Capsules were trading +3.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Natural Capsules PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹216.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Natural Capsules' management team is headed by:
- C. Rangachar - NEC
- Prasanna Junnarkar - CFO
- Shilpa Burman - CCO
- Sunil Mundra - MDR
- Laxminarayan Moondra - EDR
- Satyanarayan Mundra - EDR
- Jyothi Mundra - DRC
- Sushil Mundra - NED
- C. Gurumurthy - NID
- Anjan Roy - NID